147699-19-2

147699-19-2 structure
147699-19-2 structure
  • Name: 1-BOC-4-(2-METHANESULFONYLOXY-ETHYL)-PIPERIDINE
  • Chemical Name: tert-butyl 4-(2-methylsulfonyloxyethyl)piperidine-1-carboxylate
  • CAS Number: 147699-19-2
  • Molecular Formula: C13H25NO5S
  • Molecular Weight: 307.40600
  • Create Date: 2018-12-28 16:14:02
  • Modify Date: 2024-01-09 20:13:26

Name tert-butyl 4-(2-methylsulfonyloxyethyl)piperidine-1-carboxylate
Synonyms 1-tert-butyloxycarbonyl-4-[2-(methanesulfonyloxy)ethyl]-piperidine
1-(1-tert-Butyloxycarbonyl-piperidin-4-yl)-2-methanesulphonyloxyethane
t-butyl 4-(2-((methylsulfonyl)oxy)ethyl)-1-piperidinecarboxylate
1-Boc-4-(2-(methylsulfonyloxy)ethyl)piperidine
tert-butyl 4-[2-(methanesulfonyloxy)ethyl]piperidine-1-carboxylate
N-t-butoxycarbonyl-4-piperidylethyl methanesulfonate
1-N-BOC-4-(2-METHANESULFONYLOXYETHYL)PIPERIDINE
tert-butyl 4-(2-((methylsulfonyl)oxy)ethyl)piperidine-1-carboxylate
2-(1-tert-Butoxycarbonylpiperid-4-yl)ethyl methanesulfonate
Molecular Formula C13H25NO5S
Molecular Weight 307.40600
Exact Mass 307.14500
PSA 81.29000
LogP 3.01850
Storage condition 2-8°C
HS Code 2933399090

~99%

147699-19-2 structure

147699-19-2

Literature: MYRIAD GENETICS, INC. Patent: WO2009/65035 A1, 2009 ; Location in patent: Page/Page column 141-142 ;

~%

147699-19-2 structure

147699-19-2

Literature: Karl Thomae GmbH Patent: US5681841 A1, 1997 ;

~%

147699-19-2 structure

147699-19-2

Literature: GRUENENTHAL GmbH Patent: US2012/71461 A1, 2012 ;

~%

147699-19-2 structure

147699-19-2

Literature: GRUENENTHAL GmbH Patent: US2012/71461 A1, 2012 ;

~%

147699-19-2 structure

147699-19-2

Literature: GRUENENTHAL GmbH Patent: US2012/71461 A1, 2012 ;

~%

147699-19-2 structure

147699-19-2

Literature: SYNTA PHARMACEUTICALS CORP.; CHIMMANAMADA, Dinesh, U.; YING, Weiwen Patent: WO2013/158644 A2, 2013 ;

~%

147699-19-2 structure

147699-19-2

Literature: SYNTA PHARMACEUTICALS CORP.; CHIMMANAMADA, Dinesh, U.; YING, Weiwen Patent: WO2013/158644 A2, 2013 ;
HS Code 2933399090
Summary 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%